FOXP3 and cancer: Gut-derived SCFAs have been found to promote regeneration and proliferation of Tregs in cancer patients, including butyrate and propionate (PA) mediated Tregs differentiation through activating Foxp3 intronic enhancer CNS1 and increasing histone H3 acetylation levels [48, 119, 120].